By Editorial Staff
December 01, 2025
In the landscape of modern patient advocacy, few organizations have managed to bridge the gap between clinical necessity and emotional support as effectively as Sharsheret. As the organization marks a poignant milestone—the tenth anniversary of the passing of its founder, Rochelle Shoretz—her sons, Shlomo and Dovid Mirsky, are calling upon the global community to sustain the vital mission that has become a lifeline for over 275,000 individuals annually.
What began as an intimate gathering of five women around a dining room table in 2001 has blossomed into an international movement, fundamentally changing how Jewish families navigate the intersection of cancer, faith, and daily life.
The Genesis: A Dining Room Table Movement
The story of Sharsheret is one born of profound necessity. In 2001, when Rochelle Shoretz was diagnosed with breast cancer, the cultural landscape regarding the disease was starkly different. Cancer remained largely a taboo subject, particularly within tight-knit religious communities. Shoretz, then a young mother to Shlomo and Dovid—aged three and five respectively—found herself navigating a labyrinth of medical appointments, career demands, and the overwhelming emotional burden of parenting while ill.
The turning point came when Shoretz connected with Lauryn Weiser, another young Jewish mother facing a similar diagnosis. The two forged a bond that transcended mere acquaintance; they provided one another with the nuanced, culturally competent support that mainstream medical systems often failed to deliver.
“Mom realized the importance of linking people in similar situations,” Shlomo and Dovid Mirsky recount. “She took that idea and ran with it.” This realization formed the bedrock of Sharsheret—a Hebrew word meaning "chain"—symbolizing the connection between those who have walked the path and those just beginning their journey.
Chronology of Impact: From Local Support to Global Reach
The growth of Sharsheret over the past two decades serves as a case study in the power of grassroots philanthropy and mission-driven leadership.
- 2001: Sharsheret is founded in the aftermath of Shoretz’s diagnosis, focusing on peer-to-peer support for Jewish women.
- 2005–2010: The organization expands its scope, introducing professional psychosocial counseling, genetic counseling, and specialized resources for families, including the “Busy Box” program, which provides age-appropriate resources to children of patients.
- 2015: The organization faces its most significant challenge: the passing of its founder, Rochelle Shoretz. Despite the loss, the internal infrastructure proved robust enough to continue the expansion of services.
- 2020–2025: Sharsheret pivots to meet the digital age, integrating telehealth and expanded genetic screening outreach. It currently impacts the lives of over 275,000 people annually, establishing itself as the preeminent resource for Jewish women and families facing breast and ovarian cancer.
Addressing the Void: Why Sharsheret Matters
For many, the medical diagnosis is only the beginning of a complex struggle. Patients must contend with the "hidden" costs of cancer: the strain on marriages, the confusion of young children, the complexities of religious observance during treatment, and the persistent, nagging fear of recurrence.
The "Busy Box" and Child-Centric Care
The Mirsky brothers speak candidly about their own childhoods, noting how the "Busy Box" helped them cope with the realities of their mother’s treatment. This program is not merely a collection of toys; it is a clinical intervention designed to minimize the trauma of a parent’s illness. By providing children with tools to understand and cope with their new reality, Sharsheret ensures that the next generation is not left behind as their parents undergo treatment.
Culturally Competent Support
Sharsheret’s success lies in its ability to provide support that respects the unique cultural and religious nuances of the Jewish community. From navigating the complexities of Kashrut during hospital stays to understanding the theological questions that often arise during a health crisis, the organization offers a level of sensitivity that generic support groups often cannot replicate.
Supporting Data: The Scale of the Mission
As of 2025, the demand for Sharsheret’s services has reached an all-time high. The organization’s impact is quantified not just in the number of lives touched, but in the breadth of its programmatic reach:
- Peer Support Network: Thousands of connections made annually between newly diagnosed patients and survivors.
- Genetic Outreach: A massive increase in education regarding BRCA mutations and hereditary cancer risk within the Ashkenazi Jewish population, where the risk factor is statistically higher.
- Clinical Counseling: 24/7 access to mental health professionals who specialize in the unique stressors of cancer survivorship.
The organization’s growth from a small group to an international powerhouse demonstrates that there is a critical, unmet need for personalized, patient-centric care that goes beyond the clinical setting.
A Call to Action: The Year-End Imperative
As 2025 draws to a close, the Mirsky brothers are spearheading a year-end campaign to ensure that the "chain" remains unbroken. The campaign, accessible at link.Sharsheret.org/EOY, serves as both a fundraising effort and a tribute to the legacy of their mother.
“We know that thanks to your generosity, Mom is looking down with pride as we build a healthier and brighter future for the next generation,” they wrote in their appeal. The funds raised during this period are critical to maintaining the organization’s high standard of care and funding new initiatives to support families in the upcoming year.
Implications: The Future of Patient Advocacy
The trajectory of Sharsheret carries significant implications for the future of non-profit advocacy. It demonstrates that when an organization is built upon authentic, lived experience, it fosters a level of trust that traditional institutions often struggle to cultivate.
The Sustainability of Founders’ Legacies
A common challenge for non-profits is the "founder transition." Sharsheret’s ability to thrive ten years after the loss of its visionary founder serves as a model for organizational sustainability. By institutionalizing the values of empathy, peer support, and scientific literacy, Sharsheret has moved from a personality-driven organization to a movement-driven institution.
The Future of Community-Based Medicine
As medicine becomes increasingly technological and fragmented, the human element—the "chain" of support—becomes more vital. Sharsheret’s model suggests that future health outcomes will be increasingly dependent on the strength of community-based support networks that complement medical treatment.
Conclusion
As the Jewish community prepares to celebrate the festival of Chanukah—a holiday dedicated to the triumph of light over darkness and the dedication of the Temple—the story of Sharsheret resonates with particular intensity. It is a story of turning personal tragedy into a beacon of light for others.
Rochelle Shoretz may have missed the milestones of her sons’ lives, but her legacy lives on in every family that finds solace, every child who finds a moment of play, and every woman who finds the strength to face her diagnosis with dignity. As the Mirsky brothers note, the work is far from finished. The chain must continue to grow, and the support must continue to flow.
For those wishing to contribute to this enduring legacy, the time to act is now. By supporting Sharsheret, donors are not just funding an organization; they are ensuring that no one in the Jewish community ever has to face the daunting journey of cancer alone.
To join Shlomo and Dovid Mirsky in their mission, visit link.Sharsheret.org/EOY.
About the Author
